$16.10
+0.660 (+4.27%)
At Close: Jun 03, 2026
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
10:56am, Monday, 25'th May 2026
The mean of analysts' price targets for Biodesix (BDSX) points to a 104.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
Biodesix to Participate in Upcoming Investor Conferences
06:00am, Thursday, 21'st May 2026
LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participat
Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals Includes real-world clinical data from Biodesix researchers and independent Healthcare Professional
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
10:55am, Thursday, 07'th May 2026
The mean of analysts' price targets for Biodesix (BDSX) points to a 103.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript
07:53pm, Monday, 04'th May 2026
Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
06:10pm, Monday, 04'th May 2026
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $1.26. This compares to a loss of $1.6 per share a year ago.
Biodesix Announces First Quarter 2026 Results and Highlights
04:01pm, Monday, 04'th May 2026
Delivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in Q1 2026; Increased FY 2026 Revenue Guidance to $108-114 million, mid-point reflects 25% growth; Conf
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
06:00am, Monday, 20'th Apr 2026
LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarte
Comparing Biodesix (NASDAQ:BDSX) & Bausch + Lomb (NYSE:BLCO)
04:32am, Friday, 10'th Apr 2026
Biodesix (NASDAQ: BDSX - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on
Biodesix Recognized as a Top Workplace for Third Consecutive Year
01:19pm, Thursday, 09'th Apr 2026
Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Culture Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
11:43am, Monday, 06'th Apr 2026
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing Includes novel proteomic and genomic approaches to
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test's consistent clinical performance across nodule sizes and patient populations A retrospective pooled analysis of 1,
Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High?
10:55am, Thursday, 19'th Mar 2026
The mean of analysts' price targets for Biodesix (BDSX) points to an 86.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
10:41am, Thursday, 19'th Mar 2026
Here is how Biodesix, Inc. (BDSX) and Coherus Oncology (CHRS) have performed compared to their sector so far this year.
Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
01:52pm, Wednesday, 11'th Mar 2026
Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Sign In
Buy BDSX